TORONTO, Feb. 18, 2021 /CNW/ - Fresenius Kabi Canada, a health care company that specializes in medicines and technologies for infusion, transfusion and clinical nutrition, announced today it has ...
Safety, tolerability through 24 months was consistent with 12-month tofacitinib analysis. The approval for Idacio was based on a review of data that showed similar pharmacokinetics, efficacy, safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results